Rayence appoints Bill Cioffi as Vice President of Business Development

Published on:

Fort Lee, New Jersey, January 8, 2015 – Rayence Inc. announced the appointment of Bill Cioffi as Vice President of Business Development. Cioffi, an industry veteran who spent the majority of 35 year career in management positions at Fujifilm Medical Systems and later Del Medical, joined Rayence in mid-2014 as Director of Sales and Marketing. “Since joining Rayence, Bill’s knowledge of digital radiography, and the industry as a whole, has resulted in significant gains for the Company,” said Leo Park, President of Rayence Inc. “Under his guidance, we have greatly enhanced our approach to the market,” Park went on to say.

In his new role, Cioffi will focus on expanding Rayence’s product portfolio. He also will continue to head the sales and marketing groups for the Company.  

Related Content

Warning: Sidelined reactor could trigger medical isotope shortage
Malpractice watchers: Radiologists, imaging societies should bone up on the ‘science of visual perception’
ACR shares guidance for radiology providers facing IV supply shortages after hurricane
Incidental finding characteristics that warrant communication
AI implementation improves when radiology staff concerns are considered
Hospital organization sees impressive returns from POCUS integration

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.